Dr C Jefferson Hood Iii, PHD | |
772 Mccurdy Ave S, Rainsville, AL 35986-5211 | |
(256) 279-7505 | |
Not Available |
Full Name | Dr C Jefferson Hood Iii |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 772 Mccurdy Ave S, Rainsville, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457407660 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | MT 2087 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr C Jefferson Hood Iii, PHD 1508 Tate Rd Nw, Fort Payne, AL 35968-3045 Ph: (864) 357-9568 | Dr C Jefferson Hood Iii, PHD 772 Mccurdy Ave S, Rainsville, AL 35986-5211 Ph: (256) 279-7505 |
News Archive
The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation.
Researchers investigating the biochemical characteristics behind several everyday diseases have discovered a new chromosomal region to be strongly associated with the bad cholesterol, low density lipoprotein, (LDL).
British scientists from Imperial College London say women who are exposed to hairspray in the workplace during pregnancy have more than double the risk of having a son with the genital birth defect hypospadias.
Merck, known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a Marketing Authorization Application (MAA) for pembrolizumab (MK-3475), the company's investigational anti-PD-1 antibody, for the treatment of advanced melanoma.
› Verified 8 days ago